Informa


COVID-19 Action Plan completed and some signs of hope

16/11/20 -"Our target price moves from 484p to 565p after we revisited our model following Informa’s November 2020 update on its COVID-19 Action Plan. After issuing a £150m follow-on Sterling bond (maturing ..."

Pages
58
Language
English
Published on
16/11/20
You may also be interested by these reports :
06/05/24
The reduction in our target price derives from the updating of our EPS forecasts and the impact on the DCF (see the respective comments). In ...

03/05/24
JC Decaux reported Q124 numbers bang in line with expectations. The group is at last back to a “normalized” level of activity after the huge hit from ...

01/05/24
The Q124 trading statement was fairly reassuring, beating the street’s expectations despite the unfavourable context that had previously been flagged ...

01/05/24
Wolters Kluwer published a good Q1 trading update with positive organic growth in all divisions once again in line with the market expectations. The ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO